Vaccine information for BILH clinicians and staff to use when providing care and service to patients.
Communications Toolkit
Pre-Vaccination Assessment Tools
- Primary Series COVID-19 Vaccine Schedule
- Booster Dose COVID-19 Vaccine Schedule
- Guidance for COVID-19 Vaccination for People who are Moderately or Severely Immunocompromised
- BILH COVID-19 Vaccination & Therapeutics Categorization of Immunosuppression
- Triage of People with a History of Allergies or Allergic Reactions
- BILH COVID-19 Vaccines – Vaccinator Screening Tool (2/17/22)
- BILH Injectable Medications Containing Polyethlyene Glycol 3350
- BILH COVID-19 Vaccination Guidance for Patients Undergoing Operative, Non-operative and Radiologic Procedures (3/11/21)
- BILH Allergy Providers
General Information
- Massachusetts Homebound Vaccination Program Resource Guide and Information
- FDA Vaccine Information and Emergency Use Authorization Sheet – Pfizer
- FDA Vaccine Information and Emergency Use Authorization Sheet – Moderna
- FDA – Provider EUA Fact Sheet – Janssen/Johnson & Johnson
- CDC – Interim Clinical Considerations for Use of mRNA COVID-19 Vaccines Currently Authorized in the United States
Post-Vaccination Side Effects Management
- Characteristics of Reactions/Side Effects Following mRNA (Pfizer-BioNTech & Moderna) Vaccine and Eligibility for Second Dose
- BILH Allergy Providers
- CDC and FDA – Vaccine Adverse Event Reporting System (VAERS) Reporting